 = Emerging. More than 5 years before clinical availability.
|
 = Expected to be clinically available in 1 to 4 years.
|
 = Clinically available now.
|
|
|
| Description | Y/N | Source |
| Grants | yes | NIH |
| Salary | yes | Thermofisher, CIL |
| Board Member | yes | Integrated Proteomics |
| Stock | yes | Integrated Proteomics |
| Expenses | no | |
| IP Royalty | yes | University of Washington |
| Planning to mention or discuss specific products or technology of the company(ies) listed above: | no |